We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2 (EHTLAGCRGD2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02356276
Recruitment Status : Unknown
Verified October 2017 by Affiliated Cancer Hospital & Institute of Guangzhou Medical University.
Recruitment status was:  Recruiting
First Posted : February 5, 2015
Last Update Posted : October 31, 2017
Tianjin Medical University Cancer Institute and Hospital
Nanfang Hospital of Southern Medical University
Zhejiang Cancer Hospital
The Second Hospital of Hebei Medical University
Chinese PLA General Hospital
Henan Cancer Hospital
Harbin Medical University
Central South University
Guangdong Provincial People's Hospital
Wuhan Union Hospital, China
Sun Yat-sen University
Hebei Medical University Fourth Hospital
Guangdong Provincial Hospital of Traditional Chinese Medicine
Information provided by (Responsible Party):
Affiliated Cancer Hospital & Institute of Guangzhou Medical University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022